Arvinas (NASDAQ:ARVN) continues to gain attention in Nasdaq Futures, advancing in targeted protein degradation therapies for ...

Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...

This technology giant can be a smart way to play quantum computing without betting on any single technology.

There is a dangerous lie circulating in Nigeria today, subtle yet persistent, whispered in music lyrics, amplified on social media, and normalised in everyday conversations .

AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical utility in soft tissue tumor ablation. The expanded approval covers NanoKnife’s ...

Quantum computing is putting today’s digital security on a clock, and ASX-listed Codeifai is positioning for what comes after. ... Read More The post Quantum Doomsday clock is ticking, and this ASX ...

Halozyme Therapeutics is entering a powerful earnings inflection. FY25 revenue grew 38% to $1.397 billion. Check out why I am bullish on HALO stock.

Novo shares slump after the Danish drugmaker’s experimental obesity drug fails to beat Lilly’s treatment in an 84-week trial.

Researchers find that OCD brains recruit more regions to perform simple sequences, revealing new targets for TMS therapy and symptom assessment.

Novo Nordisk (NYSE:NVO) is widely associated with therapies for chronic metabolic conditions, including diabetes and weight management. Demand drivers in this area are shaped by clinical guidelines, ...

Nemesio Oseguera Cervantes, better known as El Mencho, is one of the most powerful drug traffickers in the world today. But who exactly is he? And why is his name synonymous with violence and power?

Prenzler Group initiates coverage of the clinical-stage, psilocin-focused Entropy Neurodynamics. ... Read More The post New research highlights Entropy’s leading position in the psychedelic ...